Purpose: This prospective and bi-centric study was conducted in order to determine the impact of antidiabetic treatments (AD) on (18)F-FDG bowel uptake in type 2 diabetic patients.
Methods: Fifty-five patients with previously diagnosed and treated type 2 diabetes mellitus (group 1) were divided in two subgroups: AD treatment including metformin (n=32; group 1a) and AD treatment excluding metformin (n=23; group 1b). The 95 patients without diabetes mellitus made up controls (group 2). (18)F-FDG uptake in small intestine and colon was visually graded and semi-quantitatively measured using the maximum standardized uptake value.
Results: (18)F-FDG bowel uptake was significantly increased in AD patients (group 1) as compared to controls (group 2) (p<0.001). Bowel uptake was significantly higher in AD patients including metformin (group 1a) as compared to AD patients excluding metformin (group 1b) (p<0.01), whose bowel uptake was not significantly different from controls (group 2). A metformin treatment was predictive of an increased bowel uptake in the small intestine (odds ratio OR=16.9, p<0.0001) and in the colon (OR=95.3, p<0.0001), independently of the other factors considered in the multivariate analysis. Bowel uptake pattern in the patients treated with metformin was typically intense, diffuse and continuous along the bowel, strongly predominant in the colon, in both the digestive wall and lumen.
Conclusion: This study emphasizes that metformin significantly increases (18)F-FDG uptake in colon and, to a lesser extent, in small intestine. It raises the question of stopping metformin treatment before an (18)F-FDG PET/CT scan is performed for intra-abdominal neoplasic lesion assessment.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00259-007-0563-6 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[Rectal bleeding after positron emission tomography].
Rev Med Suisse
December 2024
Service de médecine nucléaire et d'imagerie moléculaire, Département de radiologie médicale, Centre hospitalier universitaire vaudois, 1011 Lausanne.
Article Synopsis
- A 60-year-old patient with cirrhosis from alcohol use is hospitalized due to stone cholangitis and undergoes an endoscopic procedure that leads to severe upper digestive bleeding.
- The patient's condition worsens with signs of bacteremia, raising concerns about potential endocarditis, prompting a PET-CT scan for further evaluation.
- After undergoing the PET-CT, the patient experiences rectal bleeding; during some PET-CT preparations, heparin is used to enhance imaging quality.
PET biodistribution study of subcutaneous and intravenous administration of adalimumab in an inflammatory bowel disease model.
Int J Pharm
January 2025
Molecular Imaging and Pharmacokinetic Modelling Group, CIMUS, University of Santiago de Compostela, Santiago de Compostela, Spain; Nuclear Medicine and Molecular Imaging Group, University Clinical Hospital, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.
Monoclonal antibodies targeting tumor necrosis factor-alpha (antiTNF-α) are used for patients with immuno-mediated illness as inflammatory bowel disease (IBD). However, 20-40 % of IBD patients do not respond to these therapies, and increasing knowledge of biodistribution could optimize their use and consequently their effectiveness. The aim of this study is to compare the biodistribution of adalimumab after intravenous (IV) and subcutaneous (SC) administration using Positron Emission Tomography (PET) imaging in IBD animal models.
View Article and Find Full Text PDF18F-FDG-PET and other imaging modalities in the diagnosis and management of inflammatory bowel disease.
Am J Nucl Med Mol Imaging
October 2024
Department of Radiology, University of Pennsylvania Philadelphia, Pennsylvania, The United States.
Inflammatory bowel disease (IBD), which encompasses ulcerative colitis (UC) and Crohn's disease (CD), is a chronic inflammatory condition of the gastrointestinal (GI) tract that presents complex diagnostic and management challenges. Early detection and treatment of IBD is paramount, as IBD can present with serious complications, including bowel perforation, arthritis, and colorectal cancer. Most forms of diagnosis and therapeutic management, like ileocolonoscopy and upper endoscopy are highly invasive and require extensive preparation at great discomfort to patients.
View Article and Find Full Text PDFCombined [18F]-Fluorodeoxyglucose Positron Emission Tomography-MR Imaging: A Promising Tool for Diagnostics of Small Bowel Crohn's Disease.
Dig Dis
November 2024
Department of Gastroenterology, Turku University Hospital, Turku, Finland.
Introduction: Diagnostics of small bowel Crohn's disease (CD) can be difficult. Combined positron emission tomography-magnetic resonance enterography (PET-MRE) can be used to evaluate intestinal metabolism, but clinical use has been limited due to accessibility, costs, absence of standardized methods, and diagnostic thresholds. Our aim was to show that combined PET-MRE can be used to diagnose active small bowel CD.
View Article and Find Full Text PDFRegular Exercise Training Induces More Changes on Intestinal Glucose Uptake from Blood and Microbiota Composition in Leaner Compared to Heavier Individuals in Monozygotic Twins Discordant for BMI.
Nutrients
October 2024
Turku PET Centre, University of Turku, 20521 Turku, Finland.
Background/objectives: Obesity impairs intestinal glucose uptake (GU) (intestinal uptake of circulating glucose from blood) and alters gut microbiome. Exercise improves intestinal insulin-stimulated GU and alters microbiome. Genetics influence the risk of obesity and gut microbiome.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!